Clinical trial
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
NCT00004660 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00004660 |
|---|---|
| Title | Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy |
| Official title | Phase II Randomized Controlled Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Mayo Clinic |
| Status | Completed |
| Study type | Interventional |
| Conditions | Graves' Disease |
| Intervention type | Radiation |
| Interventions | Radiotherapy, Sham treatment |
| Enrollment | 42 |
| Start date | Jun 1, 1993 |
| Primary completion | Jan 1, 1998 |
| Completion | Jan 1, 1998 |
| First posted | Feb 25, 2000 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: